Capricor Therapeutics, Inc. (CAPR) Ownership
CAPR ownership summary
as of October 18, 2026- Institutions
- 74.1% of shares outstanding
- Insiders
- 9.44% of shares outstanding
- Shares outstanding
- 58.1M
- Float
- 45.5M shares available to trade
- Short interest
- 35.75% 18.8M shares short
- Days to cover
- 4.84 short interest down 4.3% vs prior month
- Institutions 74.10%
- Insiders 9.44%
- Other investors 16.46%
CAPR top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 7.13% | 4.1M | $27.8M | +723,246 (+21.1%) | June 30, 2026 |
| 2 | TANG CAPITAL MANAGEMENT LLC | 7.05% | 4.1M | $27.5M | +700,000 (+20.6%) | June 30, 2026 |
| 3 | Suvretta Capital Management, LLC | 7.04% | 4.1M | $27.5M | +274,184 (+7.2%) | June 30, 2026 |
| 4 | State Street Corp | 5.84% | 3.4M | $22.8M | +1.2M (+55.7%) | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 3.95% | 2.3M | $15.4M | +269,942 (+13.3%) | June 30, 2026 |
| 6 | The Goldman Sachs Group Inc | 2.71% | 1.6M | $10.6M | +666,155 (+73.0%) | June 30, 2026 |
| 7 | RA Capital Management, LLC | 2.59% | 1.5M | $10.1M | — | June 30, 2026 |
| 8 | Boxer Capital Management, LLC | 2.40% | 1.4M | $9.4M | +805,156 (+136.5%) | June 30, 2026 |
| 9 | Geode Capital Management, LLC | 2.36% | 1.4M | $9.2M | +253,960 (+22.7%) | June 30, 2026 |
| 10 | FMR Inc | 1.96% | 1.1M | $7.6M | +365,081 (+47.3%) | June 30, 2026 |
| 11 | Citadel Advisors Llc | 1.40% | 814K | $5.5M | +275,212 (+51.0%) | June 30, 2026 |
| 12 | Mercer Global Advisors Inc. | 1.38% | 803K | $5.4M | +399,733 (+99.2%) | June 30, 2026 |
| 13 | Soleus Capital Management, L.P. | 1.31% | 762K | $5.1M | +761,737 (0.0%) | June 30, 2026 |
| 14 | Morgan Stanley - Brokerage Accounts | 1.18% | 685K | $4.6M | +260,696 (+61.5%) | June 30, 2026 |
| 15 | Vanguard Portfolio Management, LLC | 1.09% | 636K | $4.3M | +256,873 (+67.7%) | June 30, 2026 |
| 16 | UBS Group AG | 1.07% | 620K | $4.2M | +247,677 (+66.6%) | June 30, 2026 |
| 17 | DG Capital Management, LLC | 1.05% | 612K | $4.1M | +219,499 (+56.0%) | June 30, 2026 |
| 18 | Ikarian Capital, LLC | 1.04% | 604K | $4.1M | +76,200 (+14.4%) | June 30, 2026 |
| 19 | Northern Trust Corp | 0.87% | 504K | $3.4M | +85,989 (+20.6%) | June 30, 2026 |
| 20 | Balyasny Asset Management LLC | 0.84% | 487K | $3.3M | +189,713 (+63.9%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 19 holders added 8.0M shares and 0 cut 0.
CAPR top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | State Street® SPDR® S&P® Biotech ETF | 3.08% | 1.8M | $12.0M | −34,250 (−1.9%) | September 30, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 2.85% | 1.7M | $11.1M | — | August 31, 2026 |
| 3 | iShares Russell 2000 ETF | 2.42% | 1.4M | $9.4M | −16,256 (−1.1%) | September 30, 2026 |
| 4 | Fidelity Small Cap Index | 1.01% | 588K | $3.9M | +5,056 (+0.9%) | July 31, 2026 |
| 5 | iShares Russell 2000 Growth ETF | 0.86% | 500K | $3.4M | −633 (−0.1%) | September 30, 2026 |
| 6 | Vanguard Russell 2000 ETF | 0.53% | 309K | $2.1M | +7,624 (+2.5%) | August 31, 2026 |
| 7 | JPM Thmtcs Gentc Thrps C2 dist USD | 0.30% | 174K | $1.2M | +1,947 (+1.1%) | August 31, 2026 |
| 8 | Vanguard Health Care ETF | 0.24% | 141K | $945,332 | +612 (+0.4%) | August 31, 2026 |
| 9 | Schwab Small Cap Index | 0.22% | 131K | $876,554 | — | August 31, 2026 |
| 10 | Fidelity Extended Market Index | 0.20% | 116K | $780,225 | −135,045 (−53.7%) | August 31, 2026 |
| 11 | Nuveen Equity Index R6 | 0.19% | 111K | $742,347 | — | August 31, 2026 |
| 12 | Stt Strt SPDR® Russell2000 US SmCapETF | 0.18% | 103K | $693,841 | +4,960 (+5.0%) | August 31, 2026 |
| 13 | iShares Russell 2000 Small-Cap Idx Instl | 0.17% | 101K | $674,570 | — | August 31, 2026 |
| 14 | A4Investments SICAV SIF ACCI IlanaA2EURH | 0.17% | 100K | $671,000 | — | September 30, 2026 |
| 15 | Fidelity Total Market Index | 0.17% | 100K | $669,645 | — | August 31, 2026 |
| 16 | Vanguard US Momentum Factor ETF | 0.15% | 85K | $571,229 | +39,745 (+87.6%) | June 30, 2026 |
| 17 | Fidelity Series Total Market Index | 0.14% | 80K | $535,693 | — | August 31, 2026 |
| 18 | Direxion Daily S&P Biotech Bull 3X ETF | 0.13% | 77K | $518,307 | +2,270 (+3.0%) | September 30, 2026 |
| 19 | Strategic Advisers U.S. Total Stock | 0.12% | 72K | $486,475 | +71,400 (+6,490.9%) | August 31, 2026 |
| 20 | iShares Core S&P Total US Stock Mkt ETF | 0.12% | 67K | $450,731 | +60 (+0.1%) | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
CAPR insider transactions
latest 4| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-02 | Karimah Es Sabar | Sell | $32.00 | 7,529 | $240,928 |
| 2026-04-01 | Karimah Es Sabar | Sell | $31.03 | 53,735 | $1.7M |
| 2026-03-31 | Anthony Bergmann | Sell | $30.13 | 25,000 | $753,250 |
| 2026-03-31 | Karimah Es Sabar | Sell | $30.17 | 61,265 | $1.8M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
CAPR shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns CAPR
Institutional investors own 74.1% of Capricor Therapeutics's shares and insiders 9.44%. The largest holder is BlackRock Inc with 7.13% of the shares (4.1M), as of June 30, 2026. Among the top 20 institutions, 19 added shares and 0 reduced their stake in the latest filings. Short interest is 35.75% of the float, or 4.84 days of average trading volume. The share count rose 3,185.2% since 2014.
Related: CAPR analyst forecast, CAPR key metrics. See the CAPR stock overview for the latest quote and news.
CAPR ownership FAQ
Who owns the most Capricor Therapeutics stock?
The largest shareholders of Capricor Therapeutics are BlackRock Inc (7.13%), TANG CAPITAL MANAGEMENT LLC (7.05%), Suvretta Capital Management, LLC (7.04%), State Street Corp (5.84%), Vanguard Capital Management, LLC (3.95%).
What percentage of Capricor Therapeutics is owned by institutions?
Institutions hold 74.1% of Capricor Therapeutics's shares outstanding; insiders hold 9.44%.
Which funds own Capricor Therapeutics?
The largest fund holders of Capricor Therapeutics are State Street® SPDR® S&P® Biotech ETF (3.08%), Vanguard MStar Total Stk Mkt Idx Invest (2.85%), iShares Russell 2000 ETF (2.42%), Fidelity Small Cap Index (1.01%), iShares Russell 2000 Growth ETF (0.86%).
What is Capricor Therapeutics's short interest?
18.8M shares of Capricor Therapeutics were sold short, 35.75% of the float; at the average daily volume it would take 4.84 days to cover.
Are insiders buying or selling Capricor Therapeutics?
Of the latest 4 reported insider transactions in Capricor Therapeutics (since March 31, 2026), 0 were purchases and 4 were sales.
How many shares of Capricor Therapeutics are outstanding?
Capricor Therapeutics has 58.1M shares outstanding, of which 45.5M are in the public float.